Boston Scientific raises annual profit forecast on strong demand for heart devices

April 24 (Reuters) – Medical device maker Boston Scientific raised its annual profit forecast on Wednesday as the company banks on resilient demand for its heart devices, with post-pandemic elective surgical procedures picking up pace.

The company now expects 2024 adjusted earnings per share between $2.29 and $2.34, compared with its previous forecast of $2.23 to $2.27 per share. (Reporting by Christy Santhosh and Puyaan Singh in Bengaluru; Editing by Shounak Dasgupta)

(c) Copyright Thomson Reuters 2024. Click For Restrictions – https://agency.reuters.com/en/copyright.html